Yutrepia

1 articles
The Motley FoolThe Motley Fool··Cory Renauer

Liquidia CCO Liquidates $2.8M Stock Position Amid Strong Product Sales Growth

Liquidia's Chief Commercial Officer sold 80,000 shares worth $2.8M through pre-arranged plan while retaining substantial holdings as flagship product Yutrepia drives record quarterly profits.
LQDAbiotechnologyinsider sale